Biomay

Biomay wants to be a worldwide leader in research, discovery and development of disease modifying allergy therapeutics. Our products will dramatically improve the quality of life of patients by offering long-term cure for their disease. We discover and develop recombinant allergy vaccines with a superior efficacy and safety profile. These innovative vaccines are based on cutting edge science for immunotherapy and prophylaxis that we generate in close cooperation with our academic partners. The clinical efficacy of our products is demonstrated under the highest medical standards. We cooperate with leading allergy specialists and industrial partners to revolutionize allergy treatment solutions for the patients’ benefit. Manufacturing of our own and our clients’ development products complies with the highest quality standards. Additionally, we support our clients by offering highly professional GMP contract manufacturing services.